Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Custodiol-N vs. Custodiol in Aortic Valve Surgery
NCT02098772Phase 3Completed
- Sponsor
- Franz Köhler Chemie
- Start
- May 2014
- Primary completion
- Nov 2018
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of histidine-tryptophan-ketoglutarate solution (modified) (2 arms), sponsored by Franz Köhler Chemie. Primary endpoint: Peak value for Creatine Kinase-MB at 24 hours. Started May 2014; status: completed.
02
Drugs
histidine-tryptophan-ketoglutarate solution (modified)
Beyond the preview
Go deeper on NCT02098772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02098772.